Avocado Oil for Health & Longevity

Evidence Review created on 09/27/2026 using AI4L + evidence-mcp / Grok 4.1

Also known as: Persea americana oil, Persea gratissima oil

Motivation

Avocado oil is the cooking fat pressed from avocado flesh. Most of it is the same kind of fat that dominates olive oil, plus smaller amounts of vitamin E and plant pigments. Adults focused on long-term health look at it as a high-heat substitute for butter.

The research record is thinner than that of olive oil or the whole fruit. Reports of lower blood pressure, better blood fats, and less liver fat come mainly from animals. In people, the clearest work is one breakfast in which butter was swapped for the oil. Store surveys have also found many bottles oxidized or mixed with cheaper oils.

This review examines what avocado oil is, the human and animal evidence on benefits and harms, and how dose, quality, and lab follow-up are described. It keeps the culinary oil separate from the whole fruit and from the joint capsule made from the non-fat parts of avocado and soybean.

Benefits - Risks - Protocol - Conclusion

High-level discussions and primary papers that name avocado oil in a health or nutrition context, excluding systematic reviews and reference-site entries.

Peter Attia’s site search returned no page that names avocado oil, so none is listed. A Huberman Lab episode with Rhonda Patrick names avocado oil only as a possible alternative to seed oils, and a FoundMyFitness clip does the same, so neither is listed. Lifespan.io had no article on avocado oil.

Grokipedia

  • Avocado oil

    The page summarizes production from avocado pulp, fatty-acid composition, and the difference between refined and unrefined oil, which orients the culinary product before the primary studies.

Examine

No dedicated Examine.com article on avocado oil was found. The site has a page on the whole avocado fruit and a separate page on avocado-soybean unsaponifiables, which is a different preparation and is not linked here.

ConsumerLab

  • Avocado Oil Review

    ConsumerLab tested retail avocado oils for freshness, fatty-acid purity, and taste, and it summarizes how virgin and refined grades differ and where quality failures have shown up.

Systematic Reviews

No systematic reviews or meta-analyses for Avocado Oil were found on PubMed as of September 27, 2026.

Mechanism of Action

Avocado oil is the triglyceride fraction (the main fat molecules) of avocado flesh. Oleic acid, an 18-carbon monounsaturated fatty acid, usually accounts for about half to three-quarters of those fatty acids, with smaller shares of palmitic acid (a saturated fat), linoleic acid (omega-6, a polyunsaturated fat), and palmitoleic acid (another monounsaturated fat). When oleic-acid-rich fat replaces palmitic-rich fat such as butter, the liver tends to clear more low-density lipoprotein (LDL, the cholesterol linked to artery disease) particles. It has not been shown as a months-long fasting change from this oil.

The oil also carries plant sterols, especially beta-sitosterol, which compete with cholesterol for intestinal uptake, plus alpha-tocopherol (vitamin E) and lutein (a yellow plant pigment). Human studies have not shown that these minor compounds move a disease marker beyond the fat itself.

Colored compounds in vegetables are poorly absorbed without fat. Oil in the meal helps form the droplets that carry those pigments into chylomicrons (the particles that move meal fat into the blood). In a crossover feeding study, avocado oil and whole avocado increased that absorption to a similar degree (Unlu et al., 2005), which points to the lipid rather than to the fiber of the fruit.

Avocado oil is not a single drug. It has no receptor selectivity and no cytochrome P450 (CYP, drug-breakdown enzymes) clearance of its own. Meal fat appears in blood over a few hours and clears as chylomicrons. Lower blood pressure, mitochondrial changes, and less liver fat are rodent findings, not in people.

Historical Context & Evolution

Avocado flesh has been eaten in Mesoamerica for millennia. Selling the pressed oil is more recent. In the twentieth century it moved from cosmetics into the cooking aisle beside olive oil, helped by a similar main fatty acid and by hotter-pan tolerance when refined. A non-triglyceride fraction of avocado was later combined with a soybean fraction as avocado-soybean unsaponifiables, a capsule studied for osteoarthritis. That capsule is not the oil in a bottle, and joint results for the capsule do not carry over to culinary use.

Cardiometabolic interest followed the fatty-acid resemblance to olive oil. Rodent work then reported lower blood pressure, improved blood lipids, and less liver fat when the oil was added to damaging diets (Márquez-Ramírez et al., 2018; Carvajal-Zarrabal et al., 2014). A 2019 narrative review still described little human evidence (Flores et al., 2019). A 2021 review reached the same conclusion for cancer, diabetes, and cardiovascular disease: animal and cell data, not human disease outcomes (Cervantes-Paz & Yahia, 2021). Small human meal studies have since measured carotenoid absorption and the hours after one breakfast in which butter was replaced by the oil. The record moved from animal-only work to a few acute human observations, still without trials of heart attack, stroke, or death. Retail testing after 2020 also showed many bottles oxidized or mixed with cheaper oils (a UC Davis report on Green & Wang, 2020), so the historical product and a given kitchen bottle are not always the same thing.

Expected Benefits

High 🟩 🟩 🟩

No benefit reaches High: the human surrogate (a lab stand-in) finding is a single acute meal test, and the other controlled human study measured carotenoid absorption rather than a clinical event or a second trial of fasting LDL cholesterol, blood pressure, or long-term blood sugar.

Medium 🟩 🟩

Postprandial (after-meal) response when butter is replaced

Replacing butter with Hass avocado oil at one heavy breakfast improved four-hour glucose, insulin, LDL cholesterol, triglycerides, C-reactive protein (a general inflammation marker), and interleukin-6 (an inflammatory signal) in 13 overweight adults (a Lund University record of Furlan et al., 2017). High-density lipoprotein (HDL, cholesterol carried back from the arteries) did not differ. Eggs and bacon stayed, so the contrast is the fat. A review finds disease effects in animals and cells, not in human endpoint trials (Cervantes-Paz & Yahia, 2021). One acute lab shift, not a replicated fasting result.

Magnitude: Direction favors lower post-meal glucose, LDL cholesterol, triglycerides, and C-reactive protein over 4 hours when butter is replaced; the abstract reports a statistically significant difference and reports no absolute outcome figure in mg/dL.

Low 🟩

Carotenoid absorption from salad

Adding 24 g avocado oil to salad raised alpha-carotene, beta-carotene, and lutein absorption in 11 adults, similar to 150 g of fruit (Unlu et al., 2005). Versus salad alone, that fruit raised 9.5-hour exposure 7.2-, 15.3-, and 5.1-fold. The endpoint is pigment appearance in plasma, not a disease event.

Magnitude: 24 g of avocado oil matched 150 g of avocado fruit, which increased alpha-carotene, beta-carotene, and lutein absorption 7.2-, 15.3-, and 5.1-fold versus salad without avocado; the abstract gives no separate fold-change for the oil alone.

Speculative 🟨

Blood pressure in hypertensive rats

Rats with induced hypertension had lower blood pressure after 45 days of avocado oil, similar to losartan (an angiotensin-blocking drug) (Márquez-Ramírez et al., 2018). No human trial was found.

Blood lipids in sucrose-fed rats

Sucrose-fed rats given avocado oil had lower triglycerides and LDL cholesterol, with little HDL change, similar to olive oil (Carvajal-Zarrabal et al., 2014). Evidence is limited to that animal experiment.

Fatty liver in high-fat, high-fructose rats

In rats, a high-fat, high-fructose diet produced fatty liver; avocado oil reduced that fat and improved mitochondrial energy handling (García-Berumen et al., 2022). No human liver-fat trial was found.

Glucose handling in sucrose-fed rats

Sucrose-fed rats given 10% and 20% avocado oil had lower insulin resistance than sucrose alone. At 30%, insulin resistance matched the standard-diet control (Del Toro-Equihua et al., 2016). No human glucose trial was found.

Benefit-Modifying Factors

  • Baseline lipids: A swap away from saturated fat matters more when LDL cholesterol is above the person’s target. Avocado-oil-specific fasting trials by baseline lipid level were not found.

  • Age: The breakfast-swap study enrolled adults at a mean age of about 65. Older adults often clear meal fat more slowly. No separate benefit dose is defined.

  • Sex: No avocado-oil trial reports a sex difference in benefit. Sex-specific expectations are not supported.

  • Existing conditions: Fat malabsorption, or symptomatic gallstones (stones that already cause gallbladder pain), can limit how much fat is eaten, which would shrink any meal-level effect.

  • Genetics: Apolipoprotein E (APOE) variants can change the LDL response to dietary fat. No avocado-oil genotype study was found, so this is a reason to watch the lab, not a dosing rule.

Potential Risks & Side Effects

High 🟥 🟥 🟥

No risk reaches High: repeated human trials have not documented a clinical adverse event, or a worsening of blood pressure, LDL cholesterol, glucose, or liver enzymes, from avocado oil.

Medium 🟥 🟥

No risk reaches Medium: no single controlled trial and no consistent observational cohort has linked avocado oil itself to a clinical harm or to a worse validated safety marker.

Low 🟥

Oxidized or adulterated retail oil

Fifteen of 22 retail samples were oxidized before the label date, and three were nearly all soybean oil (a UC Davis report on Green & Wang, 2020). Nuclear magnetic resonance (NMR) can separate authentic oil from common adulterants (Tang et al., 2021). Illness in buyers was not measured.

Magnitude: Fifteen of 22 retail samples were oxidized before the expiration date, and at least 82% were oxidized or mixed with other oils; three bottles were nearly all soybean oil.

Allergy in people already sensitized to avocado

Avocado is a core food in latex-fruit syndrome, in which immunoglobulin E (IgE, the allergy antibody) to latex also recognizes avocado proteins (Blanco, 2003). Itching, hives, or anaphylaxis (a severe allergic reaction) can follow in sensitized people. Oil challenge trials are lacking; residual protein is more plausible in unrefined oil.

Magnitude: Reactions occur in people already sensitized to avocado or latex, and the literature reports no incidence figure for culinary avocado oil.

Speculative 🟨

Extra energy when the oil is added on top of the diet

Oils provide about 9 kcal per gram, so adding the oil on top of the diet raises energy intake. No controlled human weight trial exists, so the basis is energy accounting only.

Risk-Modifying Factors

  • Genetics: No drug-metabolizing gene is known to change risk. The oil is a food fat, not a single drug substrate.

  • Baseline body weight: Adding the oil on top of an unchanged diet matters more when body weight is already rising. Substitution removes that concern.

  • Baseline labs: No blood test is known to change the chance of harm from the oil. The clotting test is the exception for people already on warfarin, as noted under interactions.

  • Sex: No sex difference in adverse events is reported for avocado oil.

  • Allergy history: A prior avocado or latex reaction raises the chance of an immediate reaction, especially with unrefined oil.

  • Gallbladder disease: A large fat load can trigger gallbladder pain when gallstones are already symptomatic. A teaspoon is less concerning than one large serving.

  • Age: Adults around age 65 ate the breakfast swap without a reported age-specific adverse-event rate. None is published.

  • Anticoagulant use: People on warfarin are the group in which a change in avocado fruit intake has been tied to clotting-test shifts. The oil itself is untested.

Key Interactions & Contraindications

  • Vitamin K antagonists (warfarin; drugs that slow clotting): Caution. Avocado fruit lowered the international normalized ratio (INR, a clotting test) in case reports; the oil was not studied (Blickstein et al., 1991). Steady intake, with INR rechecked after a change, limits an unexpected shift.

  • Lipase inhibitors (orlistat; drugs that block fat digestion): Caution. A large fat dose taken with orlistat increases oily spotting and urgent stools. A smaller fat serving at that dose limits that effect.

  • Over-the-counter analgesics (pain relievers; ibuprofen, acetaminophen): No interaction is established at culinary doses. No clinical consequence is documented.

  • Fat-soluble vitamin supplements (vitamins A, D, E, and K): Monitor at high doses. A fat-containing meal can increase absorption. The clinical consequence is a higher vitamin exposure, not a toxic interaction at food doses.

  • Plant-sterol supplements (beta-sitosterol products): Monitor. Both can reduce cholesterol absorption. The combined effect is not quantified and is not known to be harmful. Total sterol intake is the amount that adds up.

  • Other high-oleic oils (olive oil): Caution for energy only. Calorie effects add. No pharmacologic toxicity from using both as foods is described. Total fat stays inside the day’s intake.

Populations who should avoid Avocado Oil:

  • People with a prior immediate allergic reaction to avocado, including anaphylaxis, or with latex-fruit syndrome and a known avocado reaction.

Risk Mitigation Strategies

  • Substitution, not addition: About 14–28 g (1–2 tablespoons) in place of butter or another fat limits the extra energy that can raise body weight.

  • Verified freshness: A recent press date and a peroxide value (an oxidation measure) within draft crude (10 meq O2/kg) or refined (2 meq O2/kg) ceilings limit oxidized or soybean-substituted oil.

  • Allergy exclusion: Described practice keeps the oil away from people with a prior avocado or latex reaction, especially unrefined grades, to limit hives or anaphylaxis.

  • Steady warfarin intake: Avocado foods that stay constant, with INR rechecked after any change, avoid an unexpected loss of anticoagulation.

  • Rancid oil set aside: Described practice is to stop intake if the oil smells of paint or rotten fruit, or if it smokes early, which limits oxidized lipids.

Therapeutic Protocol

  • Culinary amount: Described use is about 14–28 g (1–2 tablespoons) with meals, in the range of the 24 g salad test, in place of butter or another cooking fat.

  • Two grades, no default: Unrefined oil keeps flavor and pigments for cold or moderate heat. Refined oil is milder and tolerates a hotter pan. Kresser and Life Extension describe both beside olive oil.

  • Time of day: With meals, especially vegetable meals when carotenoid absorption is the aim. No clock time is supported.

  • Half-life: Not a drug. Meal fat was followed for 4 hours in the breakfast study and 9.5 hours in the absorption study. No plasma half-life is published.

  • Split across meals: Spreading the oil across meals, rather than one large serving, limits gastrointestinal load and a single energy spike. No study of blood levels requires a split.

  • Genetics: No genotype-based dose exists. APOE and similar fat-response variants are a reason to watch LDL cholesterol, not to change the tablespoon count.

  • Sex: No sex-specific dose is described.

  • Age: Adults around age 65 were in the breakfast study. No lower dose for older adults is defined. This is a food, not a pediatric supplement.

  • Baseline labs: If LDL cholesterol or body weight is the reason for a fat swap, those baselines show whether a later change is real.

  • Conditions: Symptomatic gallstones, fat malabsorption, and avocado allergy argue for a smaller amount or for avoidance, as noted under risks.

Discontinuation & Cycling

  • Duration: Culinary use is open-ended. It is a food, not a course with a planned stop date.

  • Withdrawal: No withdrawal syndrome is described. Stopping simply removes that fat source. No rebound effect is documented.

  • Taper: No taper is described. The amount can stop at once.

  • Cycling: Cycling is not described for maintaining an effect. Continuous use as the usual cooking fat is the pattern discussed.

Sourcing and Quality

  • Grade: Virgin oil is unrefined, greener, and richer in pigments. Refined oil is paler, milder, and has a higher smoke point (the heat at which it starts to smoke). Both grades have failed retail purity tests.

  • What to check: A lot-specific fatty-acid profile, peroxide value, and free fatty acidity (broken-down fat). Draft ceilings often cited are 10 meq O2/kg peroxide for crude oil and 2 for refined oil, with free acidity of 0.1% for refined oil.

  • Brands: A brand name is not proof. In a UC Davis report on Green & Wang, 2020, Chosen Foods and Marianne’s refined oils were pure and not oxidized. A current certificate of analysis beats a logo.

  • Storage: Dark glass, a cool cupboard, and a closed cap slow oxidation from light, heat, and air, which is the failure seen in U.S. retail surveys (a UC Davis report on Green & Wang, 2020).

Practical Considerations

  • Time to effect: Carotenoid absorption changes within one meal (measured over 9.5 hours). Post-meal glucose and lipid differences were seen over 4 hours. Fasting changes over weeks are not established.

  • Common pitfall: Reading whole-avocado trials, or osteoarthritis results for avocado-soybean unsaponifiables, as if they were trials of the culinary oil, or pouring the oil on top of existing fats.

  • Regulatory status: The oil is sold as a food, not as an approved drug. Reviews consulted found no olive-oil-style international standard fully in force, and retail quality varies.

  • Cost and access: The oil is widely sold and is not exceptionally hard to obtain. Price does not guarantee purity; very low prices have tracked with adulteration in retail surveys.

Interaction with Foundational Habits

  • Sleep: Direction: none established. No trial links avocado oil to better or worse sleep. A very large late fat meal can slow gastric emptying; that is a general fat effect, not an oil-specific finding.

  • Nutrition: Direction: potentiating for carotenoid absorption from vegetables, because fat carries those pigments, and a substitute for saturated fat. The oil has no fiber, unlike the whole fruit. Salads are the setting when pigment uptake is the aim.

  • Exercise: Direction: none established. No trial shows a gain or a blunting of training adaptation. As calories, it can fill an energy gap; workout timing is not defined.

  • Stress management: Direction: none established. Animal work touches inflammatory markers. No human study ties the oil to cortisol or to perceived stress. No stress-specific timing follows.

Monitoring Protocol & Defining Success

Before avocado oil becomes the main added fat, a baseline lipid panel, fasting glucose, body weight, and waist circumference show the starting point. Alanine aminotransferase (ALT, a liver enzyme) is optional and only relevant if intake will be large or liver fat is already a question. Nothing in the human record makes these labs a safety gate the way a drug start would. They answer whether a fat swap is followed by a change.

Ongoing checks, if the oil stays in daily use, fit at about 8–12 weeks and then every 6–12 months. Sooner is reasonable after a large change in amount, a new warfarin dose, or a bottle that smelled rancid and was used anyway. Allergy is immediate and is not a lab finding.

Biomarker Optimal Functional Range Why Measure It? Context/Notes
LDL cholesterol <70 mg/dL (1.8 mmol/L) Artery-risk cholesterol Conventional flags often start above 100–130 mg/dL. Fasting sample.
Apolipoprotein B <80 mg/dL Count of artery-risk particles Conventional upper bounds are often 100–130 mg/dL. Pairs with LDL cholesterol.
Triglycerides <100 mg/dL (1.1 mmol/L) Meal-fat handling Conventional upper bound is often 150 mg/dL. Fasting sample.
HDL cholesterol >50 mg/dL Cholesterol-return context Conventional floors are often >40 mg/dL in men and >50 mg/dL in women.
Fasting glucose 70–90 mg/dL Sugar context for a fat swap Conventional impaired fasting glucose starts at 100 mg/dL. Fasting sample.
ALT <25 U/L in women, <33 U/L in men Liver enzyme if intake is large Conventional upper bounds are often near 40–55 U/L. Not specific to this oil.
Body weight No established target; track change from personal baseline Extra energy from added oil Also track waist at the navel. No universal kilogram target.
  • Meal tolerance: Gastrointestinal comfort after the usual amount, including loose stools after one large serving.

  • Satiety: Whether the oil replaces other food or simply adds calories, judged over one to two weeks.

  • Bottle quality: Off odors (paint, rotten fruit) or early smoking, which suggest oxidation.

  • Allergy symptoms: Itch, hives, or breathing symptoms after intake in anyone with an avocado or latex history.

Emerging Research

  • Ongoing oil trial: A recruiting crossover study gives 54 adults avocado oil or corn oil, about 4 tablespoons a day for 21 days, and tracks fasting cholesterol other than HDL (NCT07514663). ACH Food Companies, a food company, is a collaborator. No results are posted.

  • A result that could strengthen the case: A multi-week comparison of avocado oil versus butter on fasting LDL cholesterol and blood pressure would test whether the single-breakfast pattern lasts. The human gap is stated by Cervantes-Paz & Yahia, 2021.

  • A result that could weaken the case: A head-to-head trial versus olive oil with no added benefit, or a feeding study of oxidized retail oil, would narrow the claim. Oxidation and soybean substitution are documented by a UC Davis report on Green & Wang, 2020.

  • Keep the oil separate from the fruit: Whole-avocado trials add fiber and bulk, so they do not answer the oil question. The meal studies started that separation (a Lund University record of Furlan et al., 2017; Unlu et al., 2005).

Conclusion

Avocado oil is a culinary fat from avocado flesh. It is rich in the same kind of fat that dominates olive oil, with smaller amounts of vitamin E and plant pigments. For adults attending to heart disease risk, the human evidence is narrow and mostly about a single meal. One controlled comparison found a more favorable pattern of blood glucose, the cholesterol linked to artery disease, fats in the blood, and a general inflammation marker in the hours after a heavy breakfast when butter was replaced by the oil. That result is one meal in a small group. It is not a months-long change in fasting labs, and it is not a record of heart attacks or strokes. A separate small feeding study found that the oil increases absorption of vegetable pigments from salad, which speaks to nutrient availability rather than to a disease event.

Harms with a repeated human clinical record were not identified. The concerns that do have a basis are the energy in any fat that is added rather than substituted, immediate allergy in people who already react to avocado, and the chance that a retail bottle is oxidized or partly another oil. Animal experiments report lower blood pressure, shifts in blood fats, and less liver fat under damaging diets. Those findings have not been shown as human disease outcomes. The evidence describes a familiar cooking fat with a thin human record and a real problem of product quality, not a settled longevity treatment.

Top - Benefits - Risks - Protocol